Friday, September 23, 2022


Centinel Spine Announces First Commercial Use of the prodisc C Vivo Cervical Total Disc Replacement System in the Western U.S.

Centinel Spine, LLC, a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, announced the first implantation of...

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem

Guerbet (FR0000032526 GBT), a global leader in medical imaging, announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol),...

Stryker receives FDA clearance for OptaBlate Bone Tumor Ablation System

Stryker, one of the world's leading medical technology companies, announced that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S....

Infixion Bioscience is Awarded Third NIH SBIR Phase 1 Grant

Infixion Bioscience, a pre-clinical drug discovery company focused on developing gene-targeted therapeutics for the rare genetic disorder Neurofibromatosis Type 1 (NF1), announced the awarding...

GMP Cell CDMO I Peace, Inc. In Collaboration With Universities Converted Human Dermal Fibroblasts Into Oligodendrocyte

Koji Tanabe of I Peace, Inc. and a researcher Hiroko Nobuta of the University of California, San Francisco (currently assistant professor at Rutgers University)...

Hot Topics